These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22977331)

  • 1. Radiofrequency ablation of renal tumors: four-year follow-up results in 47 patients.
    Kim SD; Yoon SG; Sung GT
    Korean J Radiol; 2012; 13(5):625-33. PubMed ID: 22977331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation.
    Guo F; Hu B; Chen L; Li J
    Br J Radiol; 2019 Nov; 92(1103):20190183. PubMed ID: 31509441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
    Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
    Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation of renal tumors: our experience.
    Kim JH; Kim TH; Kim SD; Lee KS; Sung GT
    Korean J Urol; 2011 Aug; 52(8):531-7. PubMed ID: 21927699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
    Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
    J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
    Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
    J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of radiofrequency ablation of small renal tumors in patients at high anesthetic and surgical risk: urologist experience with follow-up results in the initial six months.
    Yuksel MB; Karakose A; Gumus B; Tarhan S; Atesci YZ; Akan Z
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6637-41. PubMed ID: 24377580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
    Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
    AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes.
    Ramirez D; Ma YB; Bedir S; Antonelli JA; Cadeddu JA; Gahan JC
    J Endourol; 2014 Mar; 28(3):330-4. PubMed ID: 24156661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes using real-time peripheral thermometry-guided radiofrequency ablation of small renal masses.
    Leveillee RJ; Castle SM; Gorbatiy V; Salas N; Narayanan G; Morillo-Burgos G; Jorda M; Faraday MM
    J Endourol; 2013 Apr; 27(4):480-9. PubMed ID: 23098088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
    Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
    Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Split renal function after treatment of small renal masses: comparison between radiofrequency ablation and laparoscopic partial nephrectomy.
    Acosta Ruiz V; Båtelsson S; Onkamo E; Wernroth L; Nilsson T; Lönnemark M; Dahlman P; Magnusson A
    Acta Radiol; 2021 Sep; 62(9):1248-1256. PubMed ID: 32910686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for complete renal tumor ablation using RFA.
    Acosta Ruiz V; Lönnemark M; Brekkan E; Dahlman P; Wernroth L; Magnusson A
    Acta Radiol; 2016 Jul; 57(7):886-93. PubMed ID: 26452975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.